comparemela.com
Home
Live Updates
Potential Submission - Breaking News
Pages:
Latest Breaking News On - Potential submission - Page 1 : comparemela.com
Minerva Neurosciences, Inc: Minerva Neurosciences Reports Second Quarter 2022 Financial Results and Business Updates
Company Continues to Prepare for Potential Submission of an NDA for Roluperidone in the Third Quarter of 2022WALTHAM, Mass., Aug. 09, 2022(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused
Fred ahlholm
Helen shik
Remy luthringer
Minerva neurosciences
Shik communications
Drug administration
Minerva neurosciences inc
Company continues to prepare for potential submission
Company continues
Potential submission
Third quarter
Drug administrationon april
New drug applicationon april
Executive chairman
Chief executive officer
Week open label extension
Investegate |Minerva Neurosciences, Inc Announcements | Minerva Neurosciences, Inc: Minerva Neurosciences Reports Second Quarter 2022 Financial Results and Business Updates
Investegate announcements from Minerva Neurosciences, Inc, Minerva Neurosciences Reports Second Quarter 2022 Financial Results and Business Updates
United kingdom
Fred ahlholm
Helen shik
Remy luthringer
Minerva neurosciences
Exchange commission
Exchange commission on
Shik communications
Drug administration
Minerva neurosciences inc
Company continues to prepare for potential submission
Minerva neurosciences reports second quarter
Potential submission
Third quarter
New drug application
Executive chairman
vimarsana © 2020. All Rights Reserved.